Skip to main content

Hello. It looks like you’re using an ad blocker that may prevent our website from working properly. To receive the best experience possible, please make sure any blockers are switched off and refresh the page.

If you have any questions or need help you can email us


Future vaccine supply ‘constrained’ as UK hits 25m first doses milestone

Health Secretary Matt Hancock during a media briefing in Downing Street - Credit: PA

More than 25 million people in the UK have received a first dose of coronavirus vaccine but the country faces a looming squeeze on supply and a possible block on doses from the European Union.

The milestone was passed in the first 100 days of the vaccination campaign, but the NHS warned there would be a month-long “significant reduction” in weekly vaccine supply from the end of March.

A letter to local health leaders in England said there had been “reductions in national inbound vaccines supply” and asked organisations to ensure no further appointments were uploaded to booking systems in April.

The UK’s success in its campaign has also contributed to tensions with Brussels as European Commission chief Ursula von der Leyen warned the bloc “will reflect on whether exports to countries who have higher vaccination rates than us are still proportionate”.

With the constraints on vaccine supply expected from late March, health secretary Matt Hancock told a Downing Street press conference he wanted to ensure “every last vulnerable person” receives a jab before moving on to the under-50s group.

“We will do all we can and do everything necessary to ensure the supplies that are contractually committed to protecting people in this country,” he said.

Hancock said vaccine supply was “always lumpy” but insisted the April 15 target for vaccinating over-50s would be met after the NHS wrote to local health leaders in England warning that “volumes for first doses will be significantly constrained”.

The government’s Vaccine Taskforce “currently predict this will continue for a four-week period, as a result of reductions in national inbound vaccines supply”, the letter said.

President von der Leyen said she wanted “reciprocity and proportionality” in exports, pointing out that 10 million doses of vaccine had gone from the EU to the UK.

Although Pfizer jabs were crossing the English Channel to the UK, AstraZeneca vaccines are not heading the other way, she indicated.

“We are still waiting for doses to come from the UK, so this is an invitation to show us that there are also doses from the UK coming to the European Union so that we have reciprocity,” she added.

Hancock said the supply of vaccines to the UK from EU production facilities was “fulfilling contractual responsibilities and we fully expect those contracts to be delivered on”.

He said the UK had funded research into the Oxford/AstraZeneca vaccine and had a contract for the first 100 million doses for people in the UK.

Foreign secretary Dominic Raab has accused the EU of “brinkmanship” over Von der Leyen’s stance.